BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20403070)

  • 1. Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation.
    Tran H; Collecutt M; Whitehead S; Salem HH
    Intern Med J; 2011 Apr; 41(4):337-43. PubMed ID: 20403070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROTHROMBINEX(®)-VF (PTX-VF) usage for reversal of coagulopathy: prospective evaluation of thrombogenic risk.
    Bobbitt L; Merriman E; Raynes J; Henderson R; Blacklock H; Chunilal S
    Thromb Res; 2011 Dec; 128(6):577-82. PubMed ID: 21621251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage.
    Imberti D; Barillari G; Biasioli C; Bianchi M; Contino L; Duce R; D'Incà M; Mameli L; Pinna L; Ageno W
    Pathophysiol Haemost Thromb; 2008; 36(5):259-65. PubMed ID: 19996636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
    Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
    Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
    Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
    Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.
    Leissinger CA; Blatt PM; Hoots WK; Ewenstein B
    Am J Hematol; 2008 Feb; 83(2):137-43. PubMed ID: 17729241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department.
    Hickey M; Gatien M; Taljaard M; Aujnarain A; Giulivi A; Perry JJ
    Circulation; 2013 Jul; 128(4):360-4. PubMed ID: 23770745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The outcomes of three-factor prothrombin complex concentrate (3F-PCC) in warfarin anticoagulation reversal: a prospective, single-arm, open-label, multicentre study.
    Koh HP; Jagan N; George D; Mazlan-Kepli W; Mohamed S; Lim HT; Ross NT; Mazlan AM
    J Thromb Thrombolysis; 2021 Oct; 52(3):836-847. PubMed ID: 33748900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
    Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
    Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin reversal: an audit of prescribing practices at Capital and Coast District Health Board.
    Jolliffe E; Flanagan P
    N Z Med J; 2014 Sep; 127(1403):32-40. PubMed ID: 25290497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
    Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
    Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with prothrombin complex for the emergent reversal of anticoagulation in rural geriatric trauma patients.
    Quick JA; Bartels AN; Coughenour JP; Barnes SL
    Surgery; 2012 Oct; 152(4):722-6; discussion 726-8. PubMed ID: 22943840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update of consensus guidelines for warfarin reversal.
    Tran HA; Chunilal SD; Harper PL; Tran H; Wood EM; Gallus AS;
    Med J Aust; 2013 Mar; 198(4):198-9. PubMed ID: 23451962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions.
    Ogawa S; Szlam F; Ohnishi T; Molinaro RJ; Hosokawa K; Tanaka KA
    Thromb Haemost; 2011 Dec; 106(6):1215-23. PubMed ID: 22071880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience on using prothrombin complex concentrate in urgent warfarin reversal: an Iranian survey.
    Haghpanah S; Karimi M; Bordbar M; Kamfiroozi R; Asgharzadeh H
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):277-81. PubMed ID: 22734101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.
    Huynh TK; Costello JL; Rebuck JA
    Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis.
    Baker RI; Coughlin PB; Gallus AS; Harper PL; Salem HH; Wood EM;
    Med J Aust; 2004 Nov; 181(9):492-7. PubMed ID: 15516194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal.
    Klein L; Peters J; Miner J; Gorlin J
    Am J Emerg Med; 2015 Sep; 33(9):1213-8. PubMed ID: 26143315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.